Kazakhstan | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2011 - 2023
The value of exports of commodity group 30 "Pharmaceutical products" from Kazakhstan totalled $ 49 million in 2023. Sales of commodity group 30 from Kazakhstan decreased by 33% in value terms compared to 2022. exports of commodity group 30 "Pharmaceutical products" decreased by $ 24 million (cumulative exports of commodity group 30 from Kazakhstan amounted $73 million in 2022)
Exports of commodity group 30 "Pharmaceutical products" amounted to 0.062% of total exports from Kazakhstan (cumulative merchandise exports from Kazakhstan totalled $ 78 billion in 2023). The share of commodity group 30 in total exports from Kazakhstan decreased by 0.024 p.p. compared to 2022 (it was 0.087% in 2022 and cumulative exports from Kazakhstan were equal to $ 84 billion).
Where does Kazakhstan export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Kazakhstan in 2023:
- Russia with a share of 44% (21 million US$)
- Uzbekistan with a share of 28% (14.1 million US$)
- Kyrgyz Republic with a share of 18.8% (9.27 million US$)
- Slovenia with a share of 2.89% (1.42 million US$)
- Belarus with a share of 1.24% (610 thousand US$)
- Turkmenistan - 445 thousand US$
- Moldova - 375 thousand US$
- Tajikistan - 302 thousand US$
- Latvia - 210 thousand US$
- Mongolia - 184 thousand US$
Exports structure of 30 - Pharmaceutical products - from Kazakhstan in 2023 represented by the following main commodity groups:
- 77% (38 million US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 22% (10.9 million US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 0.107% (53 thousand US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.039% (19.2 thousand US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.012% (6.1 thousand US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
The value of imports of commodity group 30 "Pharmaceutical products" to Kazakhstan totalled $ 1.95 billion in 2023. Sales of commodity group 30 to Kazakhstan went up by 5.12% compared to 2022: imports of commodity group 30 "Pharmaceutical products" went up by $ 95 million (the value of imports of commodity group 30 to Kazakhstan was equal to $1.85 billion in 2022)
Imports of commodity group 30 "Pharmaceutical products" accounted for 3.19% of total import flow to Kazakhstan (in 2023, total imports to Kazakhstan amounted to $ 61 billion). The share of commodity group 30 in total imports to Kazakhstan decreased by 0.518 p.p. compared to 2022 (it was 3.7% in 2022 and cumulative imports to Kazakhstan were equal to $ 50 billion).
Where does Kazakhstan import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Kazakhstan in 2023:
- Gambia with a share of 18.6% (363 million US$)
- Russia with a share of 7.39% (144 million US$)
- France with a share of 6.78% (132 million US$)
- India with a share of 6.54% (127 million US$)
- Italy with a share of 6.5% (126 million US$)
- USA with a share of 6.32% (123 million US$)
- Switzerland with a share of 6.28% (122 million US$)
- Ireland with a share of 4.58% (89 million US$)
- Turkey with a share of 3.96% (77 million US$)
- Slovenia with a share of 2.57% (50 million US$)
Imports structure of 30 - Pharmaceutical products - to Kazakhstan in 2023 represented by the following main commodity groups:
- 73% (1.43 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 23% (454 million US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 1.93% (37 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.869% (16.9 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.579% (11.3 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.029% (568 thousand US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
